The rising consumption of dietary supplements has triggered urgent medical warnings regarding silent toxicity and the misuse of health trends. Healthcare professionals are cautioning that the convenience of daily multivitamins and specialized wellness formulas often leads to unintentional over-supplementation, particularly with Vitamin B6, while unproven anti-aging trends like NAD+ infusions gain popularity without strong clinical backing.
Clinical Realities of Supplement Safety
While the supplement market in France has tripled in value since 2010—exceeding 3 billion euros—regulatory bodies and practitioners are increasingly concerned about the lack of clinical oversight. Irène Margaritis, head of the nutrition risk assessment unit at the French Agency for Food, Environmental and Occupational Health & Safety (ANSES), emphasizes that fortified foods and supplements cannot replicate the synergy of a balanced diet. The complex interaction of nutrients found in whole foods is biologically superior to isolated, concentrated substances. Even for athletes, a varied diet is sufficient to cover all nutritional needs, as there is no additional benefit to consuming vitamins and minerals beyond physiological requirements.
Naturopath Sandra Veziano, speaking to Radio Monaco, highlighted the specific risks of Vitamin B6 accumulation. Because this vitamin is ubiquitous in magnesium supplements, hair-care formulas, and standard multivitamins, consumers frequently exceed the European safety threshold of 12 mg per day. Chronic exposure above this limit is linked to peripheral nerve damage.
Regulatory Gap Leaves Longevity Trends Lacking Clinical Evidence
- The Regulatory Gap: Many “longevity” trends, such as NAD+ IV drips, lack solid clinical evidence to prove they are safe or effective for long-term use.
Social Media Drives Surge in Supplement Usage
The surge in supplement usage is partly driven by communication strategies on social media, which can promote products beyond regulatory claims. Nicolas Cappelaere, president of Synadiet, notes that the French market could grow even faster, as sales in North American and Asian markets are currently evolving twice as quickly. In 2025, 61% of French citizens had used supplements in the previous twenty-four months, with 78% of those users taking them regularly. For instance, the use of ashwagandha—an adaptogenic herb marketed for stress reduction—is now being flagged for its potential to stimulate thyroid function. Medical consensus now advises against its use for individuals with pre-existing thyroid conditions or those who are pregnant.
The European Food Safety Authority (EFSA) maintains a list of authorized health claims based on a 2006 regulation. Manufacturers may use pre-approved claims or submit dossiers for new functional effects, which, if approved, grant them five years of exclusivity. As Irène Margaritis notes, an effect demonstrated in a small clinical trial does not guarantee the same outcome for the general population. The industry’s reliance on “functional effects” often results in marketing that generalizes marginal benefits to all consumers.
| Substance | Primary Risk | Clinical Caveat |
|---|---|---|
| Vitamin B6 | Peripheral Neuropathy | Avoid exceeding 12 mg/day total intake. |
| NAD+ Infusions | Unproven Efficacy | Lacks solid clinical evidence. |
| Ashwagandha | Thyroid Stimulation | Contraindicated for thyroid disorders and pregnancy. |
